Marshall Wace North America’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
TS
MVP
IAM
MP
Marshall Wace North America's PGEN Position: Q3 2021 in Review
Marshall Wace North America opened a new position in Precigen (PGEN) in Q3 2021: 92,132 shares worth $459K. The stake represents ﹤0.01% of the portfolio and ranks #1148 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in PGEN as recently as Q2 2020.
Marshall Wace North America first reported a position in PGEN in Q4 2018 and has held it in 4 quarters since. 172 funds tracked by Wall St. Rank hold PGEN as of Q3 2021.
- Marshall Wace North America held 92,132 shares of Precigen worth $459K as of Q3 2021.
- Precigen was a new Marshall Wace North America position in Q3 2021.
- Precigen made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1148 holding.
- Marshall Wace North America first reported a position in Precigen in Q4 2018 and has held it in 4 quarters since.
- 172 funds tracked by Wall St. Rank held Precigen as of Q3 2021.
Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.